Bonesupport Holding AB (publ) (0RQO.L)
LSE · SEK
SEK 338.40 (+0.42%) as of
Key statistics
- EPS (TTM)
- -1.27
- 52-week range
- 74.65 – 338.40
- Revenue (TTM)
- 1.4B
- Profit margin
- 19.40%
- Volume
- 221.00k
About Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.
- Headquarters
- Lund, Sweden
- Employees
- 143
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.